Filing Details
- Accession Number:
- 0001209191-15-045956
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-22 13:34:57
- Reporting Period:
- 2015-05-20
- Filing Date:
- 2015-05-22
- Accepted Time:
- 2015-05-22 13:34:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1469443 | Arcadia Biosciences Inc. | RKDA | Agricultural Chemicals (2870) | 810571538 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1516392 | E Darby Shupp | C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-20 | 1,000,000 | $8.00 | 1,160,714 | No | 4 | P | Indirect | By Moral Compass Corporation |
Common Stock | Acquisiton | 2015-05-20 | 15,170,451 | $0.00 | 16,331,165 | No | 4 | C | Indirect | By Moral Compass Corporation |
Common Stock | Acquisiton | 2015-05-20 | 3,847,751 | $0.00 | 20,178,916 | No | 4 | C | Indirect | By Moral Compass Corporation |
Common Stock | Acquisiton | 2015-05-20 | 2,336,448 | $0.00 | 22,515,364 | No | 4 | C | Indirect | By Moral Compass Corporation |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Moral Compass Corporation |
No | 4 | C | Indirect | By Moral Compass Corporation |
No | 4 | C | Indirect | By Moral Compass Corporation |
No | 4 | C | Indirect | By Moral Compass Corporation |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2015-05-20 | 60,681,805 | $0.00 | 15,170,451 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2015-05-20 | 15,391,006 | $0.00 | 3,847,751 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2015-05-20 | 9,345,794 | $0.00 | 2,336,448 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Ms. Shupp is the CFO of Moral Compass Corporation. Moral Compass Corporation is owned by the John G. Sperling 2012 Irrevocable Trusts No. 1, 2 and 3. Ms. Shupp serves as one of three trustees of the Sperling trusts; these trustees share voting and investment power over the shares held by Moral Compass Corporation.
- The Series A Convertible Preferred Stock converted into the Issuer's common stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. This conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015.
- The Series B Convertible Preferred Stock converted into the Issuer's common stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. This conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015.
- The Series C Convertible Preferred Stock converted into the Issuer's common stock at a conversion ratio of one share of common stock for every four shares of preferred stock upon the closing of the Issuer's initial public offering of common stock, and had no expiration date. This conversion ratio reflected an adjustment due to the Issuer's 1-for-4 reverse stock split effected on May 8, 2015.